首页> 美国卫生研究院文献>Cancer Biology Therapy >miRNA profiling in vitreous humor vitreal exosomes and serum from uveal melanoma patients: Pathological and diagnostic implications
【2h】

miRNA profiling in vitreous humor vitreal exosomes and serum from uveal melanoma patients: Pathological and diagnostic implications

机译:葡萄膜黑色素瘤患者玻璃体液玻璃体外来体和血清中的miRNA分析:病理学和诊断意义

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Uveal melanoma (UM) represents approximately 5–6% of all melanoma diagnoses and up to 50% of patients succumb to their disease. Although several methods are available, accurate diagnosis is not always easily feasible because of potential accidents (e.g., intraocular hemorrhage). Based on the assumption that the profile of circulating miRNAs is often altered in human cancers, we verified whether UM patients showed different vitreous humor (VH) or serum miRNA profiles with respect to healthy controls. By using TaqMan Low Density Arrays, we analyzed 754 miRNAs from VH, vitreal exosomes, and serum of 6 UM patients and 6 healthy donors: our data demonstrated that the UM VH profile was unique and only partially overlapping with that from serum of the same patients. Whereas, 90% of miRNAs were shared between VH and vitreal exosomes, and their alterations in UM were statistically overlapped with those of VH and vitreal exosomes, suggesting that VH alterations could result from exosomal dysregulation. We report 32 miRNAs differentially expressed in UM patients in at least 2 different types of samples analyzed. We validated these data on an independent cohort of 12 UM patients. Most alterations were common to VH and vitreal exosomes (e.g., upregulation of miR-21,-34 a,-146a). Interestingly, miR-146a was upregulated in the serum of UM patients, as well as in serum exosomes. Upregulation of miR-21 and miR-146a was also detected in formalin-fixed, paraffin-embedded UM, suggesting that VH or serum alterations in UM could be the consequence of disregulation arising from tumoral cells. Our findings suggest the possibility to detect in VH and serum of UM patients “diagnostic” miRNAs released by the affected eye: based on this, miR-146a could be considered a potential circulating marker of UM.
机译:葡萄膜黑色素瘤(UM)约占所有黑色素瘤诊断的5–6%,多达50%的患者死于其疾病。尽管有几种方法可用,但由于潜在的事故(例如眼内出血),精确诊断并非总是容易可行的。基于循环miRNA的谱在人类癌症中经常改变的假设,我们验证了UM患者相对于健康对照是否显示出不同的玻璃体液(VH)或血清miRNA谱。通过使用TaqMan低密度阵列,我们分析了6名UM患者和6名健康捐献者的VH,玻璃体外来体和血清中的754个miRNA:我们的数据表明UM VH特性是唯一的,并且仅与同一患者血清中的部分重叠。鉴于VH和玻璃体外泌体之间有90%的miRNA共享,其在UM中的变化与VH和玻璃体外泌体在统计学上有重叠,这表明VH的变化可能是由于外体失调引起的。我们报告了至少2种不同类型的样品在UM患者中差异表达的32个miRNA。我们在12名UM患者的独立队列中验证了这些数据。大多数变化是VH和玻璃体外来体常见的(例如,miR-21,-34 a,-146a的上调)。有趣的是,miR-146a在UM患者的血清以及血清外泌体中均被上调。在福尔马林固定,石蜡包埋的UM中也检测到miR-21和miR-146a的上调,表明UM中的VH或血清改变可能是肿瘤细胞引起的失调的结果。我们的发现表明,有可能在UM患者的VH和血清中检测到患眼释放出的“诊断性” miRNA:基于此,miR-146a被认为是UM的潜在循环标记。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号